๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Methods for rapid detection of a recurrent nonsense mutation and documentation of phenotypic features in neurofibromatosis type 1 patients

โœ Scribed by Sascha Dublin; Vincent M. Riccardi; Karen Stephens


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
499 KB
Volume
5
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

โœฆ Synopsis


Communicated by Arthur L. Beaudet

We have developed a rapid screening method to detect a recurrent mutation in the neurofibromatosis type 1 gene. Using gene amplification and hybridization with allele-specific oligonucleotides, we screened 97 unrelated affected individuals for the recurrent C+T substitution in codon 1947. The mutation was detected in 1 patient and found to cosegregate with the disease phenotype in the patient's family. Although the estimated prevalence of this mutation is low, rapid screening of different patient cohorts would identify multiple individuals carrying the same mutation. Such data would provide the first opportunity for examining correlations between phenotypic characteristics and molecular genotype and would allow clinicians to offer early diagnosis and prenatal screening to affected families. A format for the comparison of phenotypic features in other settings is presented.


๐Ÿ“œ SIMILAR VOLUMES


Mutation screening of neurofibromatosis
โœ Hartmut Peters; Andrea Lรผder; Anja Harder; Markus Schuelke; Sigrid Tinschert ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 17 KB ๐Ÿ‘ 1 views

Neurofibromatosis type 1 is a clinically variable disorder caused mostly by small mutations within the NF1 gene on chromosome 17q11.2. We used Single Strand Conformation Polymorphism (SSCP) and radioactive sequencing to screen NF1 exons 28 and 29 from 118 unrelated patients, diagnosed with NF1 accor

EMMA, a cost- and time-effective diagnos
โœ Virginie Caux-Moncoutier; Laurent Castรฉra; Carole Tirapo; Dorothรฉe Michaux; Mari ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 250 KB

The detection of unknown mutations remains a serious challenge and, despite the expected benefits for the patient's health, a large number of genes are not screened on a routine basis. We present the diagnostic application of EMMA (Enhanced Mismatch Mutation Analysis(ยฎ) , Fluigent, Paris, France), a